ARQ 092, an orally-available, selective AKT inhibitor, attenuates neutrophil-platelet interactions in sickle cell disease
| Image |  |
|---|---|
| Description | scientific article published on 06 October 2016 |
| Author/s |
author: Brian Schwartz Robert K. Andrews |
| Publication date | October 6, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |